ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,000 | -66.7% | 500 | -70.6% | 0.00% | -50.0% |
| Q3 2016 | $3,000 | -25.0% | 1,700 | -22.7% | 0.00% | 0.0% |
| Q2 2016 | $4,000 | 0.0% | 2,200 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $4,000 | -20.0% | 2,200 | -18.5% | 0.00% | -33.3% |
| Q3 2015 | $5,000 | -66.7% | 2,700 | -15.6% | 0.00% | -66.7% |
| Q2 2015 | $15,000 | -6.2% | 3,200 | -13.5% | 0.01% | -10.0% |
| Q1 2015 | $16,000 | – | 3,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |